These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
834 related articles for article (PubMed ID: 16681946)
21. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats]. Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374 [TBL] [Abstract][Full Text] [Related]
22. Agonists of peroxisome proliferators-activated receptors (PPAR) alpha, beta/delta or gamma reduce transforming growth factor (TGF)-beta-induced proteoglycans' production in chondrocytes. Poleni PE; Bianchi A; Etienne S; Koufany M; Sebillaud S; Netter P; Terlain B; Jouzeau JY Osteoarthritis Cartilage; 2007 May; 15(5):493-505. PubMed ID: 17140817 [TBL] [Abstract][Full Text] [Related]
23. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Poncelet AC; de Caestecker MP; Schnaper HW Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488 [TBL] [Abstract][Full Text] [Related]
24. PPAR-gamma agonists inhibit TGF-beta1-induced chemokine expression in human tubular epithelial cells. Wang WM; Zhang HD; Jin YM; Zhu BB; Chen N Acta Pharmacol Sin; 2009 Jan; 30(1):107-12. PubMed ID: 19098936 [TBL] [Abstract][Full Text] [Related]
25. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta]. Li Y; Chen N; Yu HJ; Dong XP; Huang QH Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885 [TBL] [Abstract][Full Text] [Related]
26. [Effects of colchicine on synthesis and excretion of cytokines and extracellular matrix by human renal fibroblasts]. Huang WY; Sun H; Pan XQ; Fei L; Guo M; Bao HY; Chen RH; Jiang XY Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):524-8. PubMed ID: 15324573 [TBL] [Abstract][Full Text] [Related]
27. [Transforming growth factor-beta1 stimulates matrix metalloproteinase-9 production through ERK activation pathway and upregulation of Ets-1 protein]. Huang HC; Liu SY; Liang Y; Liu Y; Li JZ; Wang HY Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):328-31. PubMed ID: 15854510 [TBL] [Abstract][Full Text] [Related]
28. You-gui Pill ameliorates renal tubulointerstitial fibrosis via inhibition of TGF-β/Smad signaling pathway. Wang L; Cao AL; Chi YF; Ju ZC; Yin PH; Zhang XM; Peng W J Ethnopharmacol; 2015 Jul; 169():229-38. PubMed ID: 25922264 [TBL] [Abstract][Full Text] [Related]
29. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro. Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422 [TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation. Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168 [TBL] [Abstract][Full Text] [Related]
31. Curcumin ameliorates renal fibrosis by inhibiting local fibroblast proliferation and extracellular matrix deposition. Zhou X; Zhang J; Xu C; Wang W J Pharmacol Sci; 2014; 126(4):344-50. PubMed ID: 25452269 [TBL] [Abstract][Full Text] [Related]
32. ALK1 heterozygosity increases extracellular matrix protein expression, proliferation and migration in fibroblasts. Muñoz-Félix JM; Perretta-Tejedor N; Eleno N; López-Novoa JM; Martínez-Salgado C Biochim Biophys Acta; 2014 Jun; 1843(6):1111-22. PubMed ID: 24594380 [TBL] [Abstract][Full Text] [Related]
33. [Connective tissue growth factor synergistically with transforming growth factor beta 1 to promote renal fibrosis]. Yang M; Huang HC; Li JZ; Wang HY Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):569-73. PubMed ID: 15144592 [TBL] [Abstract][Full Text] [Related]
34. [Mechanism of transcriptional regulation of Meox1 by transforming growth factor β (1) and its effect on cell migration of adult human dermal fibroblasts]. Wei ZY; Li HS; Zhou JY; Han C; Dong H; Wu YZ; He WF; Tian Y; Luo GX Zhonghua Shao Shang Za Zhi; 2020 Mar; 36(3):224-233. PubMed ID: 32241049 [No Abstract] [Full Text] [Related]
35. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma. Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315 [TBL] [Abstract][Full Text] [Related]
36. The TGFbeta1-induced fibronectin in human renal proximal tubular epithelial cells is p38 MAP kinase dependent and Smad independent. Niculescu-Duvaz I; Phanish MK; Colville-Nash P; Dockrell ME Nephron Exp Nephrol; 2007; 105(4):e108-16. PubMed ID: 17347580 [TBL] [Abstract][Full Text] [Related]
37. [The role of transforming growth factor-β Li HH; Cai Q; Wang YP; Liu HR; Huang M Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2016 Jul; 34(7):484-488. PubMed ID: 27682480 [No Abstract] [Full Text] [Related]
38. Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro. Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY Arch Dermatol Res; 2009 Aug; 301(7):515-22. PubMed ID: 19466435 [TBL] [Abstract][Full Text] [Related]
39. [Effect and mechnism study of Shengjiyuhong cream on transdifferentiation and collagen production of normal human dermal fibroblasts]. Sun G; Zhang X; Li H; Pan L; Chen Y; Xu K; FEng D Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Sep; 32(5):365-72. PubMed ID: 30066995 [TBL] [Abstract][Full Text] [Related]
40. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]